1 intervention in Diagnostic graded Proven in humans.
Diagnostic
ApoB (Apolipoprotein B)
One of the few longevity-community favorites that is genuinely well-founded: causality is established by genetics and trials, and ApoB meaningfully improves risk assessment over LDL-C, especially in metabolically abnormal people. Not hype. The main gap is that guideline adoption and outcome-defined ApoB targets are still catching up to the mechanistic case.
G1Proven in humansStrong human (Mendelian randomization + trials establish causality)